Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (bacillus calmette-guerin)

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 2236-2239

  Seow, Shih Wee ^a   Rahmat, J N B ^a   Mohamed, A A K ^a   Mahendran, Ratha ^a   Lee, Yuan Kun ^a   Bay, Boon Huat ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bladder; Bladder neoplasms; Lactobacillus; Mycobacterium bovis

Indexed keywords

BACTERIAL PROTEIN; LIPOCORTIN 5; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CELL ASSAY; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; HUMAN; HUMAN CELL; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MAMMAL CELL; MICROBIAL ACTIVITY; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPECIES COMPARISON;

EID: 0036837243     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64362-5     Document Type: Article

References (22)

1. Lockyer, C. R. and Gillatt, D. A.: BCG immunotherapy for superficial bladder cancer. J R Soc Med, 94: 119, 2001
2. Mungan, N. A. and Witjes, J. A.: Bacillus Calmette-Guerin in superficial transitional cell carcinoma. Br J Urol, 82: 213, 1998
3. Paterson, D. L. and Patel, A.: Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. Aust N Z J Surg, 68: 340, 1998
4. Jasmer, R. M., McCowin, M. J. and Webb, W. R.: Miliary lung disease after intravesical bacillus Calmette-Guerin immunotherapy. Radiology, 201: 43, 1996
5. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W. M. et al: Demonstration of safety of probiotics-a review. Int J Food Microbiol, 44: 93, 1998
6. Naidu, A. S., Bidlack, W. and Clemens, R. A.: Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr, 39: 13, 1999
7. Okawa, T., Niibe, H., Arai, T., Sekiba, K., Noda, K., Takeuchi, S. et al: Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study. Cancer, 72: 1949, 1993
8. Matsuzaki, T., Hashimoto, S. and Yokokura, T.: Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice. Med Microbiol Immunol, 185: 157, 1996
9. Yamazaki, K., Tsunoda, A., Sibusawa, M., Tsunoda, Y., Kusano, M., Fukuchi, K. et al: The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep, 7: 977, 2000
10. Aso, Y., Akaza, H., Kotake, T., Tsukamoto, T., Imai, K. and Naito, S.: Preventive effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double blind trial. The BLP Study Group. Eur Urol, 27: 104, 1995
11. Asano, M., Karasawa, E. and Takayama, T.: Antitumor activity of Lactobacillus casei (LC9018) against experimental mouse bladder tumor (MBT-2). J Urol, 136: 719, 1986
12. Lim, B. K., Mahendran, R., Lee, Y. K. and Bay, B. H.: Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J Cancer Res, 93: 36, 2002
13. Matsuzaki, T. and Chin, J.: Modulating immune responses with probiotic bacteria. Immunol Cell Biol, 78: 67, 2000
14. Manjunath, N. and Raganathan, B.: A cytotoxic substance produced by a wild culture of Lactobacillus casei D-34 against tumour cells. Indian J Exp Biol, 27: 141, 1989
15. Fichera, G. A. and Giese, G.: Non-immunologically-mediated cytotoxicity of lactobacillus casei and its derivative peptidoglycan against tumour cell lines. Cancer Lett, 85: 93, 1995
16. Zhang, Y., Khoo, H. E. and Esuvaranathan, K.: Effects of bacillus Calmette-Guerin and interferon-alpha-2B on human bladder cancer in vitro. Int J Cancer, 71: 851, 1997
17. Durek, C., Rusch-Gerdes, S., Jocham, D. and Bohle, A.: Sensitivity of BCG to modern antibiotics. Eur Urol, 37: 21, 2000
18. Raff, M.: Cell suicide for beginners. Nature, 396: 119, 1998
19. Bohle, A.: BCG's mechanism of action-increasing our understanding. For the EBIN Group. Eur Urol, 37: 1, 2000
20. Reid, G., Bruce, A. W. and Taylor, M.: Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther, 23: 32, 1995
21. Takahashi, T., Kushiro, A., Nomoto, K., Uchida, K., Morotomi, M., Yokokura, T. et al: Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2. J Urol, 166: 2506, 2001
22. Lefrancois, L.: Basic aspects of intraepithelial lymphocyte immunobiology. In: Handbook of Mucosal Immunology. Edited by P. L. Ogra and J. Mestecky. San Diego: Academic Press, pp. 287-290, 1994